AnalystBook Research · Company Intelligence

Alphatec Holdings, Inc.

ATECNasdaq

Built from Alphatec Holdings, Inc.'s own SEC filings · updates as new filings land · sources cited throughout

or browse all covered companies

Alphatec Holdings, Inc.: Revenue grew 25% to $764M from $612M. Net loss narrowed to $143M from $162M. Free cash flow turned positive at $2.776M from a $128M outflow. Operating margin expanded 1152 bps to -10.75%. Alphatec Holdings, Inc.'s annual comparison also shows the balance-sheet screen falls in the distress range and requires business-model context.

The read at a glance✓ Audited against SEC data
  • GrowthRevenue grew 25% to $764M from $612MOK
  • ProfitabilityNet loss narrowed to $143M from $162MOK
  • Cash flowFree cash flow turned positive at $2.776M from a $128M outflowOK
  • MarginsOperating margin expanded 1152 bps to -10.75%OK
  • AccountingDistress-range screen needs contextWatch
  • Insiders3 purchases and 55 salesOK

Business

We are in the nascent stages of building a profitable international footprint for our surgical implant business focusing on a select few economically attractive markets: Australia, New Zealand and Japan.

Where the revenue comes from

Fiscal 2025, as Alphatec Holdings, Inc. reports it. History and quarterly detail are in the app.

  • Products And Services$764.2M

Leadership changes

From Alphatec Holdings, Inc.'s own filings, the day they're filed.

  • Ward W. Woods · Directors · departureeff. 2026-02-27
  • Dave Demski · director · appointmenteff. 2023-10-16
  • Tyson Marshall · President · appointmenteff. 2023-07-19

Latest filings

  • 10-Q · Quarterly report2026-08-04
  • 8-K · Company announcement2026-08-04
  • 8-K · Company announcement2026-06-11
  • 10-Q · Quarterly report2026-05-05
  • 8-K · Company announcement2026-05-05
In the full recordFree for 14 days
  • What changed🔒
  • Insider signal🔒
  • Growth quality🔒
  • Margins & accounting🔒
  • Capital allocation🔒
  • Real risks🔒
  • The long arc🔒
  • Company history🔒
  • The filings, readable — with what changed vs the prior year highlighted🔒
  • Full financial statements, industry-aware, sources cited throughout🔒
  • Forensic score history & components — the trend, not one year🔒
  • Ownership: insider buys/sells, clusters, activist stakes🔒
  • Ana — ask about Alphatec Holdings, Inc., every answer cited to the official filings🔒

Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.

14-day free trial, no credit card. For research purposes only; not investment advice.